ABBOTT LABORATORI…
USUSDABBOTT LABORATORIES (XETRA:ABL) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 4. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O Podjetju
- Spletna Stran
- abbott.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sedež
- North Chicago, United States
- Izvršni Direktor
- Robert Ford
- Zaposleni
- 73 000
- Ustanovljena
- 1888
- Na Borzi od
- 20.12.2007 (XETRA:ABL)
- Delnice v Obtoku
- 1.73 mrd. na dan 2026-06-30
- Prosto Prenosljive Delnice
- 1.72 mrd.
- Tržna Kapitalizacija
- 169.83 mrd. USD
- Notranje Osebe
- 0.49%
- Institucionalni Vlagatelji
- 81.79%
- Panoga (SIC)
- Pharmaceutical Preparations
- Pravna Oblika
- AZUK
- ISIN
- US0028241000
- LEI
- HQD377W2YR662HK5JX27
- P/E
- 33.4
- Delež Izplačila
- 66.7%
- FCF
- 7.38 mrd. USD
- Izplačilo / FCF
- 57%
- Dolg
- 34.0 mrd. USD3.7 let FCF
- Dividendni Staž
- 43 let
- Dobički, FCF in izplačane dividende — za 12 mesecev do 31.03.2026 (najnovejše poročilo podjetja).
- NAV
Opis
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Dividende
ABBOTT LABORATORIES (ABL) izplačuje dividende četrtletno. Na leto (12 mesecev do in vključno z najnovejšim napovedanim plačilom): 1.6798 EUR na delnico (plačila: 3). To je približno 1.89% trenutne cene delnice. Glede na zgodovino izplačil se naslednji datum ex-dividende pričakuje okoli 13.01.2027. Leta neprekinjenih dividend: 43.
| Ex-Datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-07-15 | — | 0.5599 EUR | 0.7/2.8 % | četrtletno | XETRA:ABL |
| 2026-04-15 | — | 0.5599 EUR | 0.6/2.5 % | četrtletno | XETRA:ABL |
| 2026-01-15 | — | 0.5599 EUR | 0.5/2.0 % | četrtletno | XETRA:ABL |
| 2025-10-15 | — | 0.5244 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2025-07-15 | — | 0.5244 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2025-04-15 | — | 0.5244 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2025-01-15 | — | 0.5244 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2024-10-15 | — | 0.4888 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2024-07-15 | — | 0.4888 EUR | 0.5/2.0 % | četrtletno | XETRA:ABL |
| 2024-04-12 | — | 0.4888 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2024-01-11 | — | 0.4888 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2023-10-12 | — | 0.4533 EUR | 0.5/2.0 % | četrtletno | XETRA:ABL |
| 2023-07-13 | — | 0.4533 EUR | 0.5/1.8 % | četrtletno | XETRA:ABL |
| 2023-04-13 | — | 0.4533 EUR | 0.5/1.9 % | četrtletno | XETRA:ABL |
| 2023-01-12 | — | 0.4533 EUR | 0.4/1.6 % | četrtletno | XETRA:ABL |
| 2022-10-13 | — | 0.4177 EUR | 0.4/1.6 % | četrtletno | XETRA:ABL |
| 2022-07-14 | — | 0.4177 EUR | 0.4/1.2 % | četrtletno | XETRA:ABL |
| 2022-04-13 | — | 0.4177 EUR | 0.4/0.8 % | četrtletno | XETRA:ABL |
| 2022-01-13 | — | 0.4177 EUR | 0.4/0.4 % | četrtletno | XETRA:ABL |
Novice Ta Teden
Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.
| 13.10.2026 | Newsroom | Top Stories |
Največji Imetniki
| Imetnik | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| BlackRock | 8.82% | 152.56 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 113.75 mio. | 2026-06-30 |
| State Street Corporation | 4.68% | 80.93 mio. | 2026-06-30 |
| Charles Schwab Investmen… | 3.45% | 59.67 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.2% | 55.3 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.83% | 49.02 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.61% | 45.14 mio. | 2026-06-30 |
| Geode Capital Management… | 2.27% | 39.22 mio. | 2026-06-30 |
| Capital Research Global… | 2.13% | 36.91 mio. | 2026-06-30 |
| Capital International In… | 2% | 34.65 mio. | 2026-06-30 |
| SCHWAB STRATEGIC TRUST-S… | 1.9% | 32.82 mio. | 2026-05-31 |
| Morgan Stanley | 1.54% | 26.61 mio. | 2026-06-30 |
| NORGES BANK | 1.35% | 23.35 mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 23.2 mio. | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 22.52 mio. | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 21.31 mio. | 2026-08-31 |
| WASHINGTON MUTUAL INVEST… | 1.01% | 17.53 mio. | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 16.58 mio. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 12.52 mio. | 2026-08-31 |
| Investment Co of America | 0.6% | 10.33 mio. | 2026-06-30 |
| STARKS DANIEL J (Directo… | ≈0.39% | 6.75 mio. | 2026-04-27 |
| FORD ROBERT B. (Chief Ex… | ≈0.03% | 522 664 | 2026-08-25 |
| ALLEN HUBERT L. (Officer… | ≈0.01% | 200 281 | 2025-02-25 |
| SALVADORI DANIEL GESUA S… | ≈0.01% | 146 377 | 2026-03-02 |
| CONROY KEVIN T (Director… | ≈0.01% | 133 737 | 2026-04-24 |
| MORELAND MARY K (Officer… | ≈0.01% | 116 136 | 2026-03-02 |
| EARNHARDT LISA D (Office… | ≈0.01% | 98 984 | 2026-02-24 |
| SCOGGINS CHRISTOPHER J (… | ≈0% | 82 123 | 2026-02-24 |
| WAINER ANDREA F (Officer… | ≈0% | 74 381 | 2025-03-03 |
| The Vanguard Group | — | — | — |
| BOUDREAU PHILIP P (Chief… | — | — | 2026-04-23 |
